Swiss National Bank chair says U.S. dollar remains dominant currency
Swiss National Bank chair says U.S. dollar remains dominant currency
Source link
Similar Posts
Gold – 11.10.2024 – Orbex Forex Trading Blog
Gold – 11.10.2024 – Orbex Forex Trading Blog XXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXX” width=”0″ style=”display:none;visibility:hidden”> Source link
Why Is Bitcoin Going Down? BTC Price Falls to Lowest Levels Since November
Bitcoin has experienced a significant decline this week, with the cryptocurrency dropping from its recent high above $100,000 to around $91,200. This sharp downturn has sent ripples through the entire crypto market, triggering substantial liquidations and traders uncertainty. Let’s check why Bitcoin is going down and analyze if BTC price can rebound in the coming…
Hong Kong’s central bank continues FX intervention | Forexlive
The Hong Kong Monetary Authority acts as Hong Kong’s central bank. HKMA buys 14.8 bn HKD to support the currency. HKD is trading at the weaker end of its band, i.e. the top of the permitted band for USD/HKD. (I seem to be doing a rinse repeat on this info, the HKMA is trying very…
SEC, Charles Schwab, Tauro Markets, and More: Executive Moves of the Week
This week, the number of executive appointments, promotions, and exits across various financial sectors significantly increased. Scope Prime onboarded industry veteran Gaby Kanj to focus on operations; newly launched Tauro Markets enlisted Carla Nemr as the Commercial Chief; Sam Chaney joined M4Markets a month after his departure from NAGA. Marex Prime Services brought an ex-IG…
Tevogen Bio CEO Reinforces Commitment to Retention of Equity Capital and Long-Term Vision
WARREN, N.J., Feb. 14, 2025 (GLOBE NEWSWIRE) — Ryan Saadi, MD, MPH, Founder and CEO of Tevogen Bio (“Tevogen Bio Holdings Inc.” or “Company”) (Nasdaq: TVGN), a clinical-stage specialty immunotherapy biotech company, reaffirms his commitment to preserving equity for shareholders. Amid ongoing discussions about financing approaches in the biotech sector, Dr. Saadi emphasizes his distinct strategy, which prioritizes…
Hidden Road Secures FINRA Broker-Dealer Licence to Expand Fixed Income Offering
On Thursday, it was announced that Hidden Road has received approval from the Financial Industry Regulatory Authority (FINRA) for its US subsidiary, Hidden Road Partners CIV US LLC, to operate as a broker-dealer. The move comes not long after it was announced that Hidden Road was acquired by Ripple for $1.25 billion. The licence enables…
